pdf文档 阿维鲁单抗作用机制---Medchemexpress---MCE中国

专业资料 > IT&计算机 > 互联网 > 文档预览
2 页 988 浏览 16 收藏 4.7分

摘要:•AvelumabInhibitorsProductData SheetAgonistsHY-108730CASNo.:1537032-82-8作⽤靶点:PD-1/PD-L1作⽤通路:Immunology/Inflammation储存⽅式:Pureform-20°C3years4°C2yearsInsolvent-80°C6months-20°C1month•Cat.No.:ScreeningLibrariesBIOLOGICALACTIVITY⽣物活性Avelumab是⼀个⼈IgG1抗PD-L1单克隆抗体,具有潜在的抗体依赖性细胞介导的细胞毒性作⽤。IC₅₀&TargetPD-1/PD-L1[1]体外研究AvelumabisafullyhumanIgG1anti-PD-L1monoclonalantibodywithpotentialantibody-dependentcell-mediatedcytotoxicityproperty.AvelumabincreasesNK-celllysis3.1-fold(P=0.01)inJHC7cellsrelativetoisotypecontrol.WhenthecellsaretreatedwithIFN-γ,AvelumabmarkedlyenhancesNK-celllysisrelativetoisotypecontrolinthefollowingcelllines:JHC7(7.56-fold;P=0.001),UM-Chor1(7.34-fold;P<0.001),U-CH2(2.6fold;

温馨提示:当前文档最多只能预览 8 页,若文档总页数超出了 8 页,请下载原文档以浏览全部内容。
阿维鲁单抗作用机制---Medchemexpress---MCE中国 第 1 页 阿维鲁单抗作用机制---Medchemexpress---MCE中国 第 2 页
本文档由 匿名用户2020-06-19 08:36:57上传分享
你可能在找
  • .:243984-11-4分⼦式:C₁₅H₁₇ClFNO₄S分⼦量:361.82作⽤靶点:Toll-likeReceptor(TLR);TNFReceptor;InterleukinRelated;Autophagy 作⽤通路:Immunology/Inflammation;Apoptosis;Autophagy储存⽅式:Powder-20°C3years4°C2years-80°C6months-20°C1monthScreeningLibrariesInsolvent SolventMass1mg5mg10mg1mM2.7638mL13.8190mL27.6381mL5mM0.5528mL2.7638mL5.5276mL10mM0.2764mL1.3819mL2.7638mLConcentration制备储备液请
    4.9 分 3 页 | 410.52 KB
  • .:1032900-25-6分⼦式:C₂₈H₃₆ClN₅O₃S分⼦量:558.14作⽤靶点:ALK;InsulinReceptor;IGF-1R作⽤通路:ProteinTyrosineKinase/RTK butsaturationunknown.SolventMass1mg5mg10mg1mM1.7917mL8.9583mL17.9167mL5mM0.3583mL1.7917mL3.5833mL10mM0.1792mL0.8958mL1.7917mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合
    4.8 分 3 页 | 403.49 KB
  • .:85622-93-1分⼦式:C₆H₆N₆O₂分⼦量:194.15作⽤靶点:DNAAlkylator/Crosslinker;Autophagy;Apoptosis作⽤通路:CellCycle/DNADamage
    4.6 分 3 页 | 410.40 KB
  • .:63-39-8分⼦式:C₉H₁₅N₂O₁₅P₃分⼦量:484.14作⽤靶点:EndogenousMetabolite作⽤通路:MetabolicEnzyme/Protease储存⽅式:Powder• butsaturationunknown.SolventMass1mg5mg10mg1mM2.0655mL10.3276mL20.6552mL5mM0.4131mL2.0655mL4.1310mL10mM0.2066mL1.0328mL2.0655mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    5.0 分 2 页 | 362.72 KB
  • .:4373-41-5分⼦式:C₃₀H₄₈O₄分⼦量:472.7作⽤靶点:NF-κB;Bacterial;HIV作⽤通路:NF-κB;Anti-infection储存⽅式:Powder-20°C3years4 SolventMass1mg5mg10mg1mM2.1155mL10.5775mL21.1551mL5mM0.4231mL2.1155mL4.2310mL10mM0.2116mL1.0578mL2.1155mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    4.7 分 3 页 | 395.79 KB
  • .:79517-01-4分⼦式:C₅₁H₇₀N₁₀O₁₂S₂分⼦量:1079.29作⽤靶点:SomatostatinReceptor作⽤通路:GPCR/GProtein;NeuronalSignaling SolventMass1mg5mg10mg1mM0.9265mL4.6327mL9.2654mL5mM0.1853mL0.9265mL1.8531mL10mM0.0927mL0.4633mL0.9265mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    4.6 分 3 页 | 404.21 KB
  • •GlycyrrhizicacidInhibitorsProductData Sheet1405-86-3分⼦式:C₄₂H₆₂O₁₆分⼦量:822.93作⽤靶点:VirusProtease作⽤通路:Anti-infection butsaturationunknown.SolventMass1mg5mg10mg1mM1.2152mL6.0759mL12.1517mL5mM0.2430mL1.2152mL2.4303mL10mM0.1215mL0.6076mL1.2152mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    5.0 分 3 页 | 403.71 KB
  • .:173531-58-3分⼦式:C₂₄H₃₄ClN₃O₉P₂分⼦量:605.94作⽤靶点:Parasite作⽤通路:Anti-infection储存⽅式:Powder-20°C3years4°C2years SolventMass1mg5mg10mg1mM1.6503mL8.2516mL16.5033mL5mM0.3301mL1.6503mL3.3007mL10mM---------Concentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    4.9 分 2 页 | 351.72 KB
  • .:59-23-4分⼦式:C₆H₁₂O₆分⼦量:180.16作⽤靶点:EndogenousMetabolite作⽤通路:MetabolicEnzyme/Protease储存⽅式:Powder-20°C3years4 SolventMass1mg5mg10mg1mM5.5506mL27.7531mL55.5062mL5mM1.1101mL5.5506mL11.1012mL10mM0.5551mL2.7753mL5.5506mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    4.7 分 3 页 | 395.23 KB
  • .:1405-10-3分⼦式:C₂₃H₅₂N₆O₂₅S₃分⼦量:908.88作⽤靶点:Bacterial;CalciumChannel作⽤通路:Anti-infection;MembraneTransporter butsaturationunknown.SolventMass1mg5mg10mg1mM1.1003mL5.5013mL11.0026mL5mM0.2201mL1.1003mL2.2005mL10mM0.1100mL0.5501mL1.1003mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶
    4.8 分 2 页 | 363.43 KB
本站APP下载(扫一扫)
活动:每周日APP免费下载全站文档
本站APP下载
热门文档